Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial.

Lucy E VivashKelly L BertramCharles B MalpasCassandra MarottaIan H HardingScott KolbeJoanne FieldingMeaghan CloughSimon J G LewisStephen TischAndrew H EvansJohn D O'SullivanThomas KimberDavid DarbyLeonid ChurilovMeng LawChristopher M HovensDennis VelakoulisTerence J O'Brien

Published in: BMJ open (2021)

Australian New Zealand Clinical Trials Registry (ACTRN12620001254987).

Keyphrases

double blind
clinical trial
placebo controlled
phase ii
study protocol
phase iii
open label
multiple sclerosis